Letters, Testimony & Comments

October 25, 2007
Dear Speaker Pelosi, Rep. Obey, Rep. Lewis, and Rep. Walsh, On behalf of the undersigned organizations, representing the life sciences industry in California and nationwide, we urge you to support a funding level for the National Institutes of...
October 24, 2007
The Biotechnology Industry Organization (BIO) appreciates this opportunity to provide the perspective of its members on the role of federally-funded university research in the patent system. BIO represents over 1,100 companies, universities and...
October 17, 2007
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) ON ISSUES TO BE ADDRESSED BY THE TECHNICAL EXPERTS GROUP ON CONCEPTS, TERMS, WORKING DEFINITIONS AND SECTORAL APPROACHES Introduction: Decision IX/12 of the Ninth Session of the Conference...
October 9, 2007
Attention: Kathleen Fonda Comments to Notice of Proposed Rulemaking Entitled: Examination of Patent Applications That Include Claims Containing Alternative Language Dear Ms. Fonda: The Biotechnology Industry Organization (BIO) appreciates...
October 3, 2007
The  Biotechnology Industry Organization (BIO) commends the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property ("IGWG") for undertaking the task of drawing up a global strategy and plan of...
September 18, 2007
BIO's comments on proposed changes to the 2009 HCPCS Level II Modification Process
September 17, 2007
BIO's comments on the Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee (MedCAC)
September 14, 2007
BIO's comments to CMS regarding proposed changes
September 7, 2007
Comments on Notice Regarding the 340B Pricing Program; Children's Hospitals
August 27, 2007
Re: Docket No. 2006D-0347, Federal Register: July 26, 2007 (Volume 72, Pages 41081- 41083) Dear Sir/Madam, The following comments are provided by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology...
August 27, 2007
The Biotechnology Industry Organization (BIO) appreciates this opportunity tp provide the perspective of its members on the Bayh-Dole Act. BIO represents over 1,100 companies, universities, and research institutions using biotechnology to research...
August 17, 2007
BIO's comments on the CMS' Proposed Decision Memorandum.
August 16, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International Business's response to the U.S. Trade Representative's Federal Register notice of July 25, 2007, requesting...